<i>GBA</i> ‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal studyKathrin Brockmann, Daniela Berg, Karin Srulijes et al.|Movement Disorders|2014Cited by 271
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot StudyMichelle M. Mielke, Inga Liepelt‐Scarfone, Rodolfo Savica et al.|PLoS ONE|2013Cited by 238
Clinical and brain imaging characteristics in leucine‐rich repeat kinase 2–associated PD and asymptomatic mutation carriersKathrin Brockmann, Thomas Gasser, Daniela Berg et al.|Movement Disorders|2011Cited by 79
The Mutation Matters: <scp>CSF</scp> Profiles of <scp>GCase</scp>, Sphingolipids, α‐Synuclein in <scp>PD<sub>GBA</sub></scp>Stefanie Lerche, Kathrin Brockmann, Daniela Berg et al.|Movement Disorders|2021Cited by 76
Parkinson's Disease: <i>Glucocerebrosidase 1</i> Mutation Severity Is Associated with CSF Alpha‐Synuclein ProfilesStefanie Lerche, Kathrin Brockmann, Daniela Berg et al.|Movement Disorders|2019Cited by 61